語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
What drives R&D alliances? Evid...
~
Han, Yongliang.
FindBook
Google Book
Amazon
博客來
What drives R&D alliances? Evidence from the biotechnology industry.
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
What drives R&D alliances? Evidence from the biotechnology industry./
作者:
Han, Yongliang.
面頁冊數:
116 p.
附註:
Adviser: Julia Porter Liebeskind.
Contained By:
Dissertation Abstracts International63-12A.
標題:
Business Administration, Management. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3073787
ISBN:
0493938729
What drives R&D alliances? Evidence from the biotechnology industry.
Han, Yongliang.
What drives R&D alliances? Evidence from the biotechnology industry.
- 116 p.
Adviser: Julia Porter Liebeskind.
Thesis (Ph.D.)--University of Southern California, 2002.
In this dissertation, we examine the motives for R&D alliances formed by large pharmaceutical companies (LPCs) with new biotechnology firms (NBFs). Using a sample of 638 R&D alliances formed by 15 global pharmaceutical firms between 1985 and 1998, we test three distinct but related explanations for R&D alliances in biotechnology. These include the transaction cost explanation; learning with flexibility; and technology preemption.
ISBN: 0493938729Subjects--Topical Terms:
626628
Business Administration, Management.
What drives R&D alliances? Evidence from the biotechnology industry.
LDR
:01974nam 2200277 a 45
001
926928
005
20110422
008
110422s2002 eng d
020
$a
0493938729
035
$a
(UnM)AAI3073787
035
$a
AAI3073787
040
$a
UnM
$c
UnM
100
1
$a
Han, Yongliang.
$3
1250511
245
1 0
$a
What drives R&D alliances? Evidence from the biotechnology industry.
300
$a
116 p.
500
$a
Adviser: Julia Porter Liebeskind.
500
$a
Source: Dissertation Abstracts International, Volume: 63-12, Section: A, page: 4380.
502
$a
Thesis (Ph.D.)--University of Southern California, 2002.
520
$a
In this dissertation, we examine the motives for R&D alliances formed by large pharmaceutical companies (LPCs) with new biotechnology firms (NBFs). Using a sample of 638 R&D alliances formed by 15 global pharmaceutical firms between 1985 and 1998, we test three distinct but related explanations for R&D alliances in biotechnology. These include the transaction cost explanation; learning with flexibility; and technology preemption.
520
$a
We conduct extensive demographic analyses to explore issues including the patterns of the development of LPCs' internal R&D capabilities in biotechnology, their R&D alliance formation behavior, and the relationship between these activities over time. We seek to interpret empirical evidence in the light of the three explanations for the motives behind R&D alliances. The results presented in this study seem to be consistent with the argument that LPCs' alliances with NBFs are motivated primarily by their need to learn while retaining organizational flexibility. The other two explanations receive only weak support.
590
$a
School code: 0208.
650
4
$a
Business Administration, Management.
$3
626628
690
$a
0454
710
2 0
$a
University of Southern California.
$3
700129
773
0
$t
Dissertation Abstracts International
$g
63-12A.
790
$a
0208
790
1 0
$a
Liebeskind, Julia Porter,
$e
advisor
791
$a
Ph.D.
792
$a
2002
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3073787
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9098885
電子資源
11.線上閱覽_V
電子書
EB W9098885
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入